RBC Life Science and Technology Fund Series F (RBF619)

RBC Life Science and Technology Fund Series F (RBF619 $75.15)
- $75.15 P/E (TTM): 23.7X
- View RBF619 Profile
- View Questions on RBF619

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

BMO S&P 500 Index ETF (ZSP $94.56)
- $94.56 P/E (TTM): 57.09X Cap: $18.85B
- View ZSP Profile
- View Questions on ZSP
iShares Core S&P/TSX Capped Composite Index ETF (XIC $43.74)
- $43.74 P/E (TTM): 5.58X Cap: $17.80B
- View XIC Profile
- View Questions on XIC
Global X Nasdaq-100 Index Corporate Class ETF (HXQ $90.29)
- $90.29 P/E (TTM): 27.96X Cap: $1.12B
- View HXQ Profile
- View Questions on HXQ
RBC Life Science and Technology Fund Series F (RBF619 $75.15)
- $75.15 P/E (TTM): 23.7X
- View RBF619 Profile
- View Questions on RBF619
Brookfield Corporation Class A Limited Voting Shares (BN $92.12)
- $92.12 P/E (TTM): 235.71X Cap: $148.93B
- View BN Profile
- View Questions on BN

Q: How do you fell about HXQ in a 15+ year RESP?
I have held RBF619 (Science and Technology for 15 years and it has done wonders but it has the fees. Any other ETF's ? ZSP? XIC? OR would you be comfortable with just BN?

Read Answer Asked by Paul on December 03, 2024

BMO Nasdaq 100 Equity Hedged To CAD Index ETF (ZQQ $159.60)
- $159.60 P/E (TTM): 72.82X Cap: $2.47B
- View ZQQ Profile
- View Questions on ZQQ
RBC Life Science and Technology Fund Series F (RBF619 $75.15)
- $75.15 P/E (TTM): 23.7X
- View RBF619 Profile
- View Questions on RBF619

Q: I hold ZQQ for tech exposure. It has grown 33.8% over the last year. I've noticed that RBF619, a Life Science and Technology fund, has grown 39.9% over the same period even with a much higher MER - 0.94% vs 0.39%. I assume this is due to the life science component in RBF619, including high performing stocks like Lilly. Would you switch ZQQ to RBF619 or are there other alternatives that provide a better tech return than ZQQ.

Read Answer Asked by Ken on June 11, 2024